Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

A Study Comparing the Effects of Trimbow to Fostair in COPD

NCT03842904 ·Status: COMPLETED ·Phase: PHASE4

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

NCT03197818 ·Status: COMPLETED ·Phase: PHASE3

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

NCT05652439 ·Status: RECRUITING

Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care

NCT04737655 ·Status: UNKNOWN ·Phase: PHASE4

Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)

NCT00996697 ·Status: COMPLETED ·Phase: PHASE4

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239421 ·Status: COMPLETED ·Phase: PHASE4

NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.

NCT06317428 ·Status: RECRUITING

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

NCT01911364 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT01572792 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01713075 ·Status: COMPLETED

Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients

NCT02969317 ·Status: COMPLETED ·Phase: PHASE1

Symbicort in Chronic Obstruktive Pulmonary Disease

NCT00612976 ·Status: COMPLETED

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

NCT00206154 ·Status: COMPLETED ·Phase: PHASE3

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients

NCT02579850 ·Status: COMPLETED ·Phase: PHASE3

Japan Long-term Safety for Tiotropium Plus Olodaterol

NCT01536262 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT03590379 ·Status: COMPLETED ·Phase: PHASE2

Bronchoreversibility and Radiologic Morphology of Emphysema

NCT02008162 ·Status: UNKNOWN

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01613326 ·Status: COMPLETED ·Phase: PHASE3

REported Outcomes in COPD With Trixeo in Real worlD

NCT05213611 ·Status: COMPLETED

A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.

NCT01703845 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan

NCT01070784 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01437397 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

NCT02085161 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01415518 ·Status: COMPLETED ·Phase: PHASE4

Analysis of the Time Taken to Triple Therapy (NOVARTIS)

NCT01786720 ·Status: UNKNOWN